Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A0A3Q8ICD2
Term | Name | Level | Count |
---|---|---|---|
GO:0001731 | formation of translation preinitiation complex | 7 | 1 |
GO:0002183 | cytoplasmic translational initiation | 4 | 1 |
GO:0002188 | translation reinitiation | 5 | 1 |
GO:0006413 | translational initiation | 3 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0022607 | cellular component assembly | 4 | 1 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 1 |
GO:0043933 | protein-containing complex organization | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0065003 | protein-containing complex assembly | 5 | 1 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003743 | translation initiation factor activity | 4 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0008135 | translation factor activity, RNA binding | 3 | 10 |
GO:0045182 | translation regulator activity | 1 | 10 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 165 | 169 | PF00656 | 0.476 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.462 |
CLV_NRD_NRD_1 | 176 | 178 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.274 |
CLV_NRD_NRD_1 | 235 | 237 | PF00675 | 0.327 |
CLV_NRD_NRD_1 | 94 | 96 | PF00675 | 0.753 |
CLV_PCSK_FUR_1 | 174 | 178 | PF00082 | 0.465 |
CLV_PCSK_FUR_1 | 3 | 7 | PF00082 | 0.645 |
CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.338 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.314 |
CLV_PCSK_KEX2_1 | 237 | 239 | PF00082 | 0.327 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.683 |
CLV_PCSK_PC1ET2_1 | 175 | 177 | PF00082 | 0.453 |
CLV_PCSK_PC1ET2_1 | 208 | 210 | PF00082 | 0.338 |
CLV_PCSK_PC1ET2_1 | 237 | 239 | PF00082 | 0.327 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.683 |
CLV_PCSK_PC7_1 | 172 | 178 | PF00082 | 0.458 |
CLV_PCSK_PC7_1 | 233 | 239 | PF00082 | 0.312 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.467 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.283 |
DOC_CKS1_1 | 54 | 59 | PF01111 | 0.703 |
DOC_MAPK_gen_1 | 195 | 203 | PF00069 | 0.464 |
DOC_MAPK_gen_1 | 276 | 284 | PF00069 | 0.535 |
DOC_MAPK_gen_1 | 84 | 93 | PF00069 | 0.565 |
DOC_USP7_MATH_1 | 278 | 282 | PF00917 | 0.461 |
DOC_USP7_UBL2_3 | 77 | 81 | PF12436 | 0.735 |
DOC_USP7_UBL2_3 | 97 | 101 | PF12436 | 0.573 |
DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.717 |
LIG_14-3-3_CanoR_1 | 176 | 185 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 212 | 221 | PF00244 | 0.477 |
LIG_14-3-3_CanoR_1 | 236 | 245 | PF00244 | 0.532 |
LIG_14-3-3_CanoR_1 | 6 | 15 | PF00244 | 0.560 |
LIG_Actin_RPEL_3 | 185 | 204 | PF02755 | 0.506 |
LIG_Actin_WH2_2 | 214 | 231 | PF00022 | 0.492 |
LIG_deltaCOP1_diTrp_1 | 234 | 239 | PF00928 | 0.444 |
LIG_FHA_2 | 178 | 184 | PF00498 | 0.458 |
LIG_GBD_Chelix_1 | 263 | 271 | PF00786 | 0.244 |
LIG_LIR_Apic_2 | 273 | 278 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 132 | 138 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 147 | 151 | PF02991 | 0.361 |
LIG_Pex14_1 | 158 | 162 | PF04695 | 0.321 |
LIG_Pex14_1 | 235 | 239 | PF04695 | 0.444 |
LIG_SH2_CRK | 135 | 139 | PF00017 | 0.387 |
LIG_SH2_CRK | 275 | 279 | PF00017 | 0.476 |
LIG_SH2_STAP1 | 162 | 166 | PF00017 | 0.347 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 283 | 286 | PF00017 | 0.404 |
LIG_SH3_3 | 288 | 294 | PF00018 | 0.540 |
LIG_SUMO_SIM_anti_2 | 199 | 205 | PF11976 | 0.279 |
LIG_SUMO_SIM_par_1 | 119 | 126 | PF11976 | 0.575 |
LIG_SUMO_SIM_par_1 | 199 | 205 | PF11976 | 0.303 |
LIG_TRAF2_1 | 118 | 121 | PF00917 | 0.562 |
LIG_TRAF2_1 | 247 | 250 | PF00917 | 0.444 |
LIG_TYR_ITIM | 133 | 138 | PF00017 | 0.403 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.647 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.670 |
MOD_Cter_Amidation | 172 | 175 | PF01082 | 0.449 |
MOD_Cter_Amidation | 210 | 213 | PF01082 | 0.261 |
MOD_Cter_Amidation | 286 | 289 | PF01082 | 0.525 |
MOD_GlcNHglycan | 147 | 151 | PF01048 | 0.419 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.546 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.779 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.672 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.739 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.712 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.719 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.582 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.472 |
MOD_NEK2_1 | 270 | 275 | PF00069 | 0.544 |
MOD_NEK2_2 | 278 | 283 | PF00069 | 0.458 |
MOD_PKA_1 | 237 | 243 | PF00069 | 0.527 |
MOD_PKA_2 | 237 | 243 | PF00069 | 0.527 |
MOD_PKA_2 | 62 | 68 | PF00069 | 0.670 |
MOD_Plk_4 | 214 | 220 | PF00069 | 0.527 |
MOD_Plk_4 | 278 | 284 | PF00069 | 0.499 |
MOD_Plk_4 | 28 | 34 | PF00069 | 0.547 |
MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.716 |
MOD_SUMO_rev_2 | 105 | 109 | PF00179 | 0.665 |
TRG_DiLeu_BaEn_1 | 280 | 285 | PF01217 | 0.545 |
TRG_DiLeu_BaLyEn_6 | 119 | 124 | PF01217 | 0.647 |
TRG_ENDOCYTIC_2 | 135 | 138 | PF00928 | 0.408 |
TRG_ER_diArg_1 | 174 | 177 | PF00400 | 0.467 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.560 |
TRG_ER_diArg_1 | 235 | 238 | PF00400 | 0.527 |
TRG_NLS_Bipartite_1 | 79 | 100 | PF00514 | 0.662 |
TRG_NLS_MonoCore_2 | 173 | 178 | PF00514 | 0.438 |
TRG_NLS_MonoExtC_3 | 287 | 292 | PF00514 | 0.554 |
TRG_NLS_MonoExtC_3 | 94 | 99 | PF00514 | 0.571 |
TRG_NLS_MonoExtN_4 | 172 | 179 | PF00514 | 0.438 |
TRG_NLS_MonoExtN_4 | 233 | 240 | PF00514 | 0.527 |
TRG_NLS_MonoExtN_4 | 3 | 9 | PF00514 | 0.594 |
TRG_NLS_MonoExtN_4 | 95 | 100 | PF00514 | 0.636 |
TRG_Pf-PMV_PEXEL_1 | 177 | 181 | PF00026 | 0.520 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IAD2 | Leptomonas seymouri | 59% | 100% |
A0A3R7KWX6 | Trypanosoma rangeli | 53% | 100% |
A4HDY3 | Leishmania braziliensis | 80% | 100% |
A4I184 | Leishmania infantum | 99% | 100% |
D0A5G8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9AXB8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QA54 | Leishmania major | 92% | 100% |
V5BN78 | Trypanosoma cruzi | 49% | 100% |